CORE--PROTOCOL REVIEW AND MONITORING SYSTEM
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM
批准号:
6989959
负责人:
STEVEN R ALBERTS
金额:
$6.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2009-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Mayo Comprehensive Cancer Center (MCCC)
oversees patient safety, data monitoring, and protocol development and review through its Protocol Review and Monitoring System (PRMS) and Data and Safety Monitoring System (DSMS). The PRMS contains several elements including the Protocol Review Committee (PRC) and Hematology Research Committee (HRC). The PRC reviews all non-hematology studies while the HRC reviews all hematology studies. The protocol review process is primarily accomplished through these two committees. A portion of PRMS activities are also accomplished through the Cancer Center Clinical Research Administrative Subcommittee (CCCRAS), and the Cancer Center Clinical Studies Oversight Committee (CCCSOC).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1
-
批准号:9914075
-
项目类别:
-
资助金额:$98.4万
-
财政年份:2019
-
负责人:STEVEN R ALBERTS
-
依托单位:
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1
-
批准号:10115645
-
项目类别:
-
资助金额:$108.41万
-
财政年份:2019
-
负责人:STEVEN R ALBERTS
-
依托单位:
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1
-
批准号:10582519
-
项目类别:
-
资助金额:$86.79万
-
财政年份:2019
-
负责人:STEVEN R ALBERTS
-
依托单位:
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1
-
批准号:10356075
-
项目类别:
-
资助金额:$93.1万
-
财政年份:2019
-
负责人:STEVEN R ALBERTS
-
依托单位:
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1
-
批准号:10062104
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2019
-
负责人:STEVEN R ALBERTS
-
依托单位:
Project 3: Inhibition of SCD1 as a therapeutic strategy for HCC
-
批准号:10251134
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2018
-
负责人:STEVEN R ALBERTS
-
依托单位:
Project 3: Inhibition of SCD1 as a therapeutic strategy for HCC
-
批准号:10468831
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2018
-
负责人:STEVEN R ALBERTS
-
依托单位:
Project 3: Inhibition of SCD1 as a therapeutic strategy for HCC
-
批准号:10006084
-
项目类别:
-
资助金额:$33.17万
-
财政年份:2018
-
负责人:STEVEN R ALBERTS
-
依托单位:
Core C: Biospecimen and Pathology Core
-
批准号:10468828
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2018
-
负责人:STEVEN R ALBERTS
-
依托单位:
Core C: Biospecimen and Pathology Core
-
批准号:10251131
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2018
-
负责人:STEVEN R ALBERTS
-
依托单位:
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
-
批准号:9242575
-
项目类别:
-
资助金额:$136.79万
-
财政年份:2014
-
负责人:STEVEN R ALBERTS
-
依托单位:
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
-
批准号:9031734
-
项目类别:
-
资助金额:$129.59万
-
财政年份:2014
-
负责人:STEVEN R ALBERTS
-
依托单位:
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
-
批准号:8604809
-
项目类别:
-
资助金额:$143.99万
-
财政年份:2014
-
负责人:STEVEN R ALBERTS
-
依托单位:
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
-
批准号:8846075
-
项目类别:
-
资助金额:$129.59万
-
财政年份:2014
-
负责人:STEVEN R ALBERTS
-
依托单位:
Clinical Research
-
批准号:7945075
-
项目类别:
-
资助金额:$47.1万
-
财政年份:2009
-
负责人:STEVEN R ALBERTS
-
依托单位:
Phase II Trial of Gemcitabine and Docetaxel
-
批准号:7042317
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:STEVEN R ALBERTS
-
依托单位:
BAY 12 9566 IN COMBINATION W/ ETOPOSIDE & CARBOPLATIN IN CANCER PATIENTS
-
批准号:6265002
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1998
-
负责人:STEVEN R ALBERTS
-
依托单位:
Early Phase Clinical Research Support
-
批准号:8682950
-
项目类别:
-
资助金额:$19.91万
-
财政年份:1997
-
负责人:STEVEN R ALBERTS
-
依托单位:
Clinical Protocol and Data Management
-
批准号:8682947
-
项目类别:
-
资助金额:$32.7万
-
财政年份:1997
-
负责人:STEVEN R ALBERTS
-
依托单位:
Early Phase Clinical Research Support
-
批准号:9554038
-
项目类别:
-
资助金额:$20.61万
-
财政年份:1997
-
负责人:STEVEN R ALBERTS
-
依托单位:
海外基金